PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival

PRMT5 Is Upregulated in HTLV-1-Mediated T-Cell Transformation and Selective Inhibition Alters Viral Gene Expression and Infected Cell Survival

Human T-cell leukemia virus type-1 (HTLV-1) is a tumorigenic retrovirus responsible for development of adult T-cell leukemia/lymphoma (ATLL). This disease manifests after a long clinical latency period of up to 2–3 decades. Two viral gene products, Tax and HBZ, have transforming properties and play...

Full description

Bibliographic Details
Main Authors:	Amanda R. Panfil, Jacob Al-Saleem, Cory M. Howard, Jessica M. Mates, Jesse J. Kwiek, Robert A. Baiocchi, Patrick L. Green
Format:	Article
Language:	English
Published:	MDPI AG 2015-12-01
Series:	Viruses
Subjects:	HTLV-1 PRMT5 transformation ATLL Tax HBZ p30 lymphoma
Online Access:	http://www.mdpi.com/1999-4915/8/1/7

Similar Items

Interplay between innate immunity and the viral oncoproteins Tax and HBZ in the pathogenesis and therapeutic response of HTLV-1 associated adult T cell leukemia
by: Hiba El Hajj, et al.
Published: (2022-07-01)

A newly identified interaction between nucleolar NPM1/B23 and the HTLV-I basic leucine zipper factor in HTLV-1 infected cells
by: Zhenlong Liu, et al.
Published: (2022-12-01)

TAX and HBZ: hFc Ɣ 1 proteins as targets for passive immunotherapy
by: Mohammad Akbarin, et al.
Published: (2022-05-01)

Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses
by: Simonis Nicolas, et al.
Published: (2012-03-01)

Stability of the HTLV-1 Antisense-Derived Protein, HBZ, Is Regulated by the E3 Ubiquitin-Protein Ligase, UBR5
by: Amanda R. Panfil, et al.
Published: (2018-01-01)

The PRMT5 inhibitor EPZ015666 is effective against HTLV-1-transformed T-cell lines in vitro and in vivo
by: Kyle Ernzen, et al.
Published: (2023-02-01)

Upregulation of Neuropilin-1 Inhibits HTLV-1 Infection
by: Wesley Kendle, et al.
Published: (2023-06-01)

Mechanisms of Oncogenesis by HTLV-1 Tax
by: Suchitra Mohanty, et al.
Published: (2020-07-01)

HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients
by: Greta Forlani, et al.
Published: (2019-04-01)

Tuning Rex rules HTLV-1 pathogenesis
by: Kazumi Nakano, et al.
Published: (2022-09-01)

The Expression of Tax and HBZ Genes in Serum-Derived Extracellular Vesicles From HTLV-1 Carriers Correlates to Proviral Load and Inflammatory Markers
by: Debora Glenda Lima de La-Roque, et al.
Published: (2022-05-01)

The Road to HTLV-1-Induced Leukemia by Following the Subcellular Localization of HTLV-1-Encoded HBZ Protein
by: Roberto S. Accolla
Published: (2022-06-01)

Distinct gene expression signatures induced by viral transactivators of different HTLV-1 subgroups that confer a different risk of HAM/TSP
by: Tadasuke Naito, et al.
Published: (2018-11-01)

A Preclinical Model for the ATLL Lymphoma Subtype With Insights Into the Role of Microenvironment in HTLV-1-Mediated Lymphomagenesis
by: Mattia Vicario, et al.
Published: (2018-06-01)

Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
by: Suchitra Mohanty, et al.
Published: (2023-05-01)

TRAF3 Is Required for NF-κB Pathway Activation Mediated by HTLV Tax Proteins
by: Stefania Fochi, et al.
Published: (2019-06-01)

Small cells lung epidermoid carcinoma in a HTLV1-infected patient: case report and literature review
by: Flávia Esper Dahy, et al.
Published: (2021-04-01)

Editorial: HTLV-1: addressing unmet research needs, volume II
by: Marcela S. Cunha, et al.
Published: (2023-10-01)

Cell Surface Markers in HTLV-1 Pathogenesis
by: Andrea K. Kress, et al.
Published: (2011-08-01)

Dynamic Roles of RNA and RNA Epigenetics in HTLV-1 Biology
by: Emily M. King, et al.
Published: (2025-01-01)

Co-expression of HBZ, TAX and FOXp3 and HTLV-1-associated myelopathy/ tropical spastic paraparesis development in HTLV-1-infected individuals: A systematic review
by: Ana Carolina Marinho Monteiro Lima, et al.
Published: (2021-01-01)

Targeting HTLV-1 Activation of NFκB in Mouse Models and ATLL Patients
by: Lee Ratner, et al.
Published: (2011-06-01)

HTLV-1 vaccination Landscape: Current developments and challenges
by: Arash Letafati, et al.
Published: (2024-08-01)

Clinical Features and Survival Outcome in Aggressive-Type Adult T-Cell Leukemia/Lymphoma Patients: Real-Life Experience of a Single Center from an HTLV-1 Endemic Country
by: Iuliana Iordan, et al.
Published: (2024-05-01)

Lesões dermatológicas em pacientes infectados pelo vírus linfotrópico humano de células T do tipo 1 (HTLV-1) Dermatologic lesions in patients infected with the human T-cell lymphotropic vírus type 1 (HTLV-1)
by: Vandack Nobre, et al.
Published: (2005-02-01)

Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation
by: Arash Letafati, et al.
Published: (2024-05-01)

HTLV-1-Mediated Epigenetic Pathway to Adult T-Cell Leukemia–Lymphoma
by: Makoto Yamagishi, et al.
Published: (2018-07-01)

Early Effects of HTLV-1 Infection on the Activation, Exhaustion, and Differentiation of T-Cells in Humanized NSG Mice
by: Otávio de Melo Espíndola, et al.
Published: (2021-09-01)

Making Sense out of Antisense Transcription in Human T-Cell Lymphotropic Viruses (HTLVs)
by: Benoit Barbeau, et al.
Published: (2011-05-01)

Potential miRNA-gene interactions determining progression of various ATLL cancer subtypes after infection by HTLV-1 oncovirus
by: Mohadeseh Zarei Ghobadi, et al.
Published: (2023-03-01)

HTLV-1-host interactions on the development of adult T cell leukemia/lymphoma: virus and host gene expressions
by: Hanieh Tarokhian, et al.
Published: (2018-12-01)

Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals
by: Arash Letafati, et al.
Published: (2024-08-01)

HTLV-1, the Other Pathogenic Yet Neglected Human Retrovirus: From Transmission to Therapeutic Treatment
by: Nicolas Futsch, et al.
Published: (2017-12-01)

Extracellular Vesicles in HTLV-1 Communication: The Story of an Invisible Messenger
by: Sarah Al Sharif, et al.
Published: (2020-12-01)

New Perspectives about Drug Candidates Targeting HTLV-1 and Related Diseases
by: Milena Cristina Martins da Silva, et al.
Published: (2023-11-01)

WRN-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells
by: R. Moles, et al.
Published: (2016-11-01)

The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing
by: Mariam Shallak, et al.
Published: (2022-08-01)

Human T-cell Leukemia Virus Type 1 and <i>Strongyloides stercoralis</i>: Partners in Pathogenesis
by: Adam Dykie, et al.
Published: (2020-10-01)

PRMT1 is an important factor for medulloblastoma cell proliferation and survival
by: Xiao Gu, et al.
Published: (2022-12-01)

Differential modulation of IL-4, IL-10, IL-17, and IFN-γ production mediated by IgG from Human T-lymphotropic virus-1 (HTLV-1) infected patients on healthy peripheral T (CD4+, CD8+, and γδ) and B cells
by: Nicolle Rakanidis Machado, et al.
Published: (2023-08-01)